Author: admin

This author has written 50 articles

020 — Ryzumvi Mydriasis Reversal Drops, Exxua for MDD, Likmez Metronidazole Liquid Formulation, DNA Test for Hereditary Cancers, Tofidence Actemra Biosimilar, Pompe Disease Combination Therapy, Subcutaneous Entyvio, NurOwn in ALS

Here is information on the latest US FDA approvals, the week of September 25 –  September 29, 2023Ryzumvi (Phentolamine Ophthalmic Solution) for Dilated PupilsThe FDA has approved Ryzumvi (phentolamine ophthalmic…

Continue Reading020 — Ryzumvi Mydriasis Reversal Drops, Exxua for MDD, Likmez Metronidazole Liquid Formulation, DNA Test for Hereditary Cancers, Tofidence Actemra Biosimilar, Pompe Disease Combination Therapy, Subcutaneous Entyvio, NurOwn in ALS

019 — Jardiance (empagliflozin) for CKD, Welireg (belzutifan) for RCC, Tevimbra (tislelizumab) for Esophageal Squamous Cell Carcinoma, Neffy Epinephrine Nasal Spray

00:00:00  Here is information on the latest US FDA approvals, the week of September 18 –  September 22, 2023.Jardiance (empagliflozin) for CKDThe FDA has approved a new indication for Jardiance…

Continue Reading019 — Jardiance (empagliflozin) for CKD, Welireg (belzutifan) for RCC, Tevimbra (tislelizumab) for Esophageal Squamous Cell Carcinoma, Neffy Epinephrine Nasal Spray

018 — Ojjaara for Anemia in Myelofibrosis, Resmetirom for NASH, COVID-19 Vaccine Update, Phenylephrine, Patisiran in ATTR-CM

Here is information on the latest US FDA approvals, the week of September 11 –  September 15, 2023.FDA Approves Ojjaara (Momelotinib) for Anemia in MyelofibrosisThe FDA has approved Ojjaara (momelotinib)…

Continue Reading018 — Ojjaara for Anemia in Myelofibrosis, Resmetirom for NASH, COVID-19 Vaccine Update, Phenylephrine, Patisiran in ATTR-CM

017 — Ilaris for Gout, Generics for ADHD, Balversa for Urothelial Cancer, INO-3107 for Recurrent Respiratory Papillomatosis, Crovalimab for PNH

Check out our free downloads: Implementing AMA Style – 8 Things to Get Right in Your Next Project Needs Assessments – 7 Essentials for Getting Funded Working With Your Medical…

Continue Reading017 — Ilaris for Gout, Generics for ADHD, Balversa for Urothelial Cancer, INO-3107 for Recurrent Respiratory Papillomatosis, Crovalimab for PNH

016 — New MS Biosimilar, RSV Maternal Immunization, Rybrevant in Advanced NSCLC, Xtandi in Early PCa

Check out our free downloads:Implementing AMA Style – 8 Things to Get Right in Your Next ProjectNeeds Assessments – 7 Essentials for Getting FundedWorking With Your Medical Writer – 8…

Continue Reading016 — New MS Biosimilar, RSV Maternal Immunization, Rybrevant in Advanced NSCLC, Xtandi in Early PCa

015 — Myeloma Bispecific, Uveal Melanoma, HD Eylea, Huntington’s, Fibrodysplasia Ossificans Progressive, CHAPLE Disease

Check out our free downloads at nascentmc.com: Implementing AMA Style – 8 Things to Get Right in Your Next Project Needs Assessments – 7 Essentials for Getting Funded Working With…

Continue Reading015 — Myeloma Bispecific, Uveal Melanoma, HD Eylea, Huntington’s, Fibrodysplasia Ossificans Progressive, CHAPLE Disease

014 — PCa Combo Pill, Multiple Myeloma BiTE, Geographic Atrophy, POLARx for AFib

Check out our free downloads at nascentmc.com: Implementing AMA Style – 8 Things to Get Right in Your Next Project Needs Assessments – 7 Essentials for Getting Funded Working With…

Continue Reading014 — PCa Combo Pill, Multiple Myeloma BiTE, Geographic Atrophy, POLARx for AFib

013 — Post-Partum Depression, Endometrial Cancer, mCRC, and Ebolavirus

Here is information on the latest US FDA approvals, the week of July 31 – August 4, 2023. Zurzuvae, the First-Ever Pill for Post-Partum DepressionThe FDA has granted approval of…

Continue Reading013 — Post-Partum Depression, Endometrial Cancer, mCRC, and Ebolavirus